Discover Our Peptide Portfolio In 2023, the FDA reviewed several peptides nominated for compounding and placed many on the 503A Category 2 list.[3] Then in 2024, the agency cited limited clinical safety data, along with concerns about immunogenicity (how the immune system might respond) and dosing variability.[4] It was a precautionary decision, and precaution is an important part of regulatory oversight
Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women
While GHK-Cu, a peptide that our bodies make, is used topically in skin cream in an attempt to reduce fine lines, it is not considered safe to inject due the lack of scientific research and the risks of triggering a potentially dangerous immune response
Chunfeng Yao: Supervision, Methodology, Investigation, Conceptualization
Frequently Asked Questions How do I know which glutathione brand is right for me